Targeting adverse effects of antiseizure medication on offspring: current evidence and new strategies for safety

References

• Devinsky O, Vezzani A, O’Brien TJ, et al. Epilepsy. Nat Rev Dis Primers. 2018 May;3(4):18024.
   Google Scholar
• Thijs RD, Surges R, O’Brien TJ, et al. Epilepsy in adults. Lancet. 2019 Feb 16;393(10172):689–701.
   PubMed Web of Science ®Google Scholar
• Chen TS, Lai MC, Huang HI, et al. Immunity, ion channels and epilepsy. Int J Mol Sci. 2022 Jun 9;23:12.
   Web of Science ®Google Scholar
• Librizzi L, Noè F, Vezzani A, et al. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol. 2012 Jul;72(1):82–90.
   PubMed Web of Science ®Google Scholar
• Godale CM, Danzer SC. Signaling pathways and cellular mechanisms regulating mossy fiber sprouting in the development of epilepsy. Front Neurol. 2018;9:298.
   PubMed Web of Science ®Google Scholar
• Devinsky O, Vezzani A, Najjar S, et al. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013 Mar;36(3):174–184.
   PubMed Web of Science ®Google Scholar
• Pitkänen A, Lukasiuk K, Dudek FE, et al. Epileptogenesis. In: Holmes GL, Noebels JL, editors. Cold spring harb perspect med. 2015 Sep 18; Vol. 5. p. 10. Cold Spring Harbor, NY.
   Google Scholar
• Henshall DC, Hamer HM, Pasterkamp RJ, et al. MicroRNAs in epilepsy: pathophysiology and clinical utility. Lancet Neurol. 2016 Dec;15(13):1368–1376.
   PubMed Web of Science ®Google Scholar
• Dingledine R, Coulter DA, Fritsch B, et al. Transcriptional profile of hippocampal dentate granule cells in four rat epilepsy models. Sci Data. 2017 May;9(4):170061.
   Google Scholar
• Manford M. Recent advances in epilepsy. J Neurol. 2017 Aug;264(8):1811–1824.
   PubMed Web of Science ®Google Scholar
• Sauro KM, Wiebe S, Dunkley C, et al. The current state of epilepsy guidelines: a systematic review. Epilepsia. 2016 Jan;57(1):13–23.
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci. 2004 Jul;5(7):553–564.
   PubMed Web of Science ®Google Scholar
• Sills GJ, Rogawski MA. Mechanisms of action of currently used antiseizure drugs. Neuropharmacology. 2020 May;15(168):107966.
   Google Scholar
• Chen Z, Brodie MJ, Liew D, et al. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 2018 Mar 1;75(3):279–286.
   PubMed Web of Science ®Google Scholar
• Löscher W, The Pharmacology KP. Clinical efficacy of antiseizure medications: from bromide salts to cenobamate and beyond. CNS Drugs. 2021 Sep;35(9):935–963.
   PubMed Web of Science ®Google Scholar
• Global, regional, and national incidence, prevalence, and years lived with disability for. 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016 Oct 8;388(10053):1545–1602.
   PubMed Web of Science ®Google Scholar
• Ngugi AK, Bottomley C, Kleinschmidt I, et al. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia. 2010 May;51(5):883–890.
   PubMed Web of Science ®Google Scholar
• Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017 Jan 17;88(3):296–303.
   PubMed Web of Science ®Google Scholar
• Vélez-Ruiz NJ, Pennell PB. Issues for Women with Epilepsy. Neurol Clin. 2016 May;34(2):411–425.
   PubMed Web of Science ®Google Scholar
• Abou-Khalil BW. Update on Antiseizure Medications 2022. Continuum (Minneap Minn). 2022 Apr 1;28(2):500–535.
   PubMedGoogle Scholar
• AA V, Cogo E, Rios P, et al. Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med. 2017 May 5;15(1):95.
   PubMedGoogle Scholar
• Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018 Jun;17(6):530–538.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Cohen MJ, Loring DW, et al. Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. JAMA Neurol. 2021 Aug 1;78(8):927–936.
   PubMed Web of Science ®Google Scholar
• Meador KJ, Baker GA, Browning N, et al. Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol. 2013 Mar;12(3):244–252.
   PubMed Web of Science ®Google Scholar
• Weckesser A, Denny E. Women living with epilepsy, experiences of pregnancy and reproductive health: a review of the literature. Seizure. 2013 Mar;22(2):91–98.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Nelson AR, Betsholtz C, et al. Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 2015 Nov 19;163(5):1064–1078.
   PubMed Web of Science ®Google Scholar
• Burton GJ, Fowden AL. The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 2015 Mar 5;370(1663):20140066.
   PubMed Web of Science ®Google Scholar
• Truchet S, Honvo-Houéto E. Physiology of milk secretion. Best Pract Res Clin Endocrinol Metab. 2017 Aug;31(4):367–384.
   PubMed Web of Science ®Google Scholar
• Wm P. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012 Nov;32(11):1959–1972.
   PubMed Web of Science ®Google Scholar
• Lin L, Yee SW, Kim RB, et al. SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov. 2015 Aug;14(8):543–560.
   PubMed Web of Science ®Google Scholar
• Theodoulou FL, Kerr ID. ABC transporter research: going strong 40 years on. Biochem Soc Trans. 2015 Oct;43(5):1033–1040.
   PubMedGoogle Scholar
• Tomson T, Battino D. Teratogenic effects of antiepileptic drugs. Lancet Neurol. 2012 Sep;11(9):803–813.
   PubMed Web of Science ®Google Scholar
• Hernández-Díaz S, Smith CR, Shen A, et al. Comparative safety of antiepileptic drugs during pregnancy. Neurology. 2012 May 22;78(21):1692–1699.
   PubMed Web of Science ®Google Scholar
• Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):193–198.
   PubMed Web of Science ®Google Scholar
• Bromley RL, Weston J, Marson AG. Maternal Use of Antiepileptic Agents During Pregnancy and Major Congenital Malformations in Children. Jama. 2017 Nov 7;318(17):1700–1701.
   PubMed Web of Science ®Google Scholar
• Lockwood PA, Pauer L, Scavone JM, et al. The Pharmacokinetics of Pregabalin in Breast Milk, Plasma, and Urine of Healthy Postpartum Women. J Hum Lact. 2016 Aug 1;32(3):1–8.
   Web of Science ®Google Scholar
• Drug Product Database (DPD). HCitDPD. Gabapentin: DPD Approved Drugs; 2018.
   Google Scholar
• Ohman I, Vitols S, Tomson T. Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy? Epilepsia. 2005 Oct;46(10):1621–1624.
   PubMed Web of Science ®Google Scholar
• Drisaldi A, Weeda E, Neyens R, et al. Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin. Neurocrit Care. 2019 Apr;30(2):301–306.
   PubMed Web of Science ®Google Scholar
• Zaccara G, Messori A, Moroni F. Clinical pharmacokinetics of valproic acid–1988. Clin Pharmacokinet. 1988 Dec;15(6):367–389.
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia. 2004;45(Suppl 6):13–18.
   PubMed Web of Science ®Google Scholar
• Buvanendran A, Kroin JS, Kari M, et al. Can a single dose of 300 mg of pregabalin reach acute antihyperalgesic levels in the central nervous system? Reg Anesth Pain Med. 2010 Nov-Dec;35(6):535–538.
   PubMed Web of Science ®Google Scholar
• Bockbrader HN, Wesche D, Miller R, et al. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet. 2010 Oct;49(10):661–669.
   PubMed Web of Science ®Google Scholar
• Fagerberg L, Hallström BM, Oksvold P, et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014 Feb;13(2):397–406.
   PubMed Web of Science ®Google Scholar
• Brukner AM, Billington S, Benifla M, et al. Abundance of P-glycoprotein and Breast Cancer Resistance Protein Measured by Targeted Proteomics in Human Epileptogenic Brain Tissue. Mol Pharm. 2021 Jun 7;18(6):2263–2273.
   PubMedGoogle Scholar
• Nucera B, Brigo F, Trinka E, et al. Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide. Ther Adv Neurol Disord. 2022;15:17562864221101687.
   Web of Science ®Google Scholar
• Tomson T, Battino D, Bonizzoni E, et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol. 2011 Jul;10(7):609–617.
   PubMed Web of Science ®Google Scholar
• Goasdoué K, Miller SM, Colditz PB, et al. Review: the blood-brain barrier; protecting the developing fetal brain. Placenta. 2017;54:111–116.
   PubMed Web of Science ®Google Scholar
• Ek CJ, Wong A, Liddelow SA, et al. Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol Lett. 2010 Aug 1;197(1):51–59.
   PubMed Web of Science ®Google Scholar
• Rambeck B, Uh J, TW M, et al. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy. Epilepsia. 2006 Apr;47(4):681–694.
   PubMed Web of Science ®Google Scholar
• AM B, Zn S, Dj N, et al. Placental passage of antiepileptic drugs at delivery and neonatal outcomes. Epilepsia. 2017 May;58(5):e82–e86.
   PubMed Web of Science ®Google Scholar
• AK B, KJ M, Karanam A, et al. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. JAMA Neurol. 2020 Apr 1;77(4):441–450.
   PubMed Web of Science ®Google Scholar
• Pienimäki P, Lampela E, Hakkola J, et al. Pharmacokinetics of oxcarbazepine and carbamazepine in human placenta. Epilepsia. 1997 Mar;38(3):309–316.
   PubMed Web of Science ®Google Scholar
• May TW, Brandt C, Helmer R, et al. Comparison of lacosamide concentrations in cerebrospinal fluid and serum in patients with epilepsy. Epilepsia. 2015 Jul;56(7):1134–1140.
   PubMed Web of Science ®Google Scholar
• Steen B, Rane A, Lönnerholm G, et al. Phenytoin excretion in human breast milk and plasma levels in nursed infants. Ther Drug Monit. 1982;4(4):331–334.
   PubMed Web of Science ®Google Scholar
• Kumagai N, Seki T, Yamada T, et al. Concentrations of zonisamide in serum, free fraction, mixed saliva and cerebrospinal fluid in epileptic children treated with monotherapy. Jpn J Psychiatry Neurol. 1993 Jun;47(2):291–292.
   PubMedGoogle Scholar
• Hovinga CA, Pennell PB. Antiepileptic drug therapy in pregnancy II: fetal and neonatal exposure. Int Rev Neurobiol. 2008;83:241–258.
   PubMed Web of Science ®Google Scholar
• Rives ML, Javitch JA, Wickenden AD. Potentiating SLC transporter activity: emerging drug discovery opportunities. Biochem Pharmacol. 2017 Jul;1(135):1–11.
   Google Scholar
• Nigam SK. What do drug transporters really do? Nat Rev Drug Discov. 2015 Jan;14(1):29–44.
   PubMed Web of Science ®Google Scholar
• Liu T, Wang Y, Wang J, et al. DYRK1A inhibitors for disease therapy: current status and perspectives. Eur J Med Chem. 2022 Feb 5;229:114062.
   PubMed Web of Science ®Google Scholar
• Tian X, Angioletti-Uberti S, Battaglia G. On the design of precision nanomedicines. Sci Adv. 2020 Jan;6(4):eaat0919.
   PubMed Web of Science ®Google Scholar
• Dickens D, Owen A, Alfirevic A, et al. Lamotrigine is a substrate for OCT1 in brain endothelial cells. Biochem Pharmacol. 2012 Mar 15;83(6):805–814.
   PubMed Web of Science ®Google Scholar
• Chen EC, Khuri N, Liang X, et al. Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1). J Med Chem. 2017 Apr 13;60(7):2685–2696.
   PubMed Web of Science ®Google Scholar
• Ghosh C, Myers R, O’Connor C, et al. Mol Neurobiol. In: Albensi BC, editor. Cortical Dysplasia in Rats Provokes Neurovascular Alterations, GLUT1 Dysfunction, and Metabolic Disturbances That Are Sustained Post-Seizure Induction. NY. Jan, 2022. p. 27.
   Google Scholar
• Lauritzen F, Perez EL, Melillo ER, et al. Altered expression of brain monocarboxylate transporter 1 in models of temporal lobe epilepsy. Neurobiol Dis. 2012 Jan;45(1):165–176.
   PubMed Web of Science ®Google Scholar
• Lauritzen F, de Lanerolle NC, Lee TS, et al. Monocarboxylate transporter 1 is deficient on microvessels in the human epileptogenic hippocampus. Neurobiol Dis. 2011 Feb;41(2):577–584.
   PubMed Web of Science ®Google Scholar
• Yang L, Lin IH, Ting CT, et al. Modulation of the transport of valproic acid through the blood-brain barrier in rats by the Gastrodia elata extracts. J Ethnopharmacol. 2021 Oct;5(278):114276.
   Google Scholar
• Ilyas-Feldmann M, Asselin MC, Wang S, et al. P-glycoprotein overactivity in epileptogenic developmental lesions measured in vivo using (R)-[(11) C]verapamil PET. Epilepsia. 2020 Jul;61(7):1472–1480.
   PubMed Web of Science ®Google Scholar
• Han H, Mann A, Ekstein D, et al. Breaking Bad: the Structure and Function of the Blood-Brain Barrier in Epilepsy. Aaps j. 2017 Jul;19(4):973–988.
   PubMed Web of Science ®Google Scholar
• Lazarowski A, Lubieniecki F, Camarero S, et al. Multidrug resistance proteins in tuberous sclerosis and refractory epilepsy. Pediatr Neurol. 2004 Feb;30(2):102–106.
   PubMed Web of Science ®Google Scholar
• Mathias AA, Hitti J, Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R963–9.
   PubMed Web of Science ®Google Scholar
• Yeboah D, Sun M, Kingdom J, et al. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol. 2006 Dec;84(12):1251–1258.
   PubMed Web of Science ®Google Scholar
• Alcorn J, Lu X, Moscow JA, et al. Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction. J Pharmacol Exp Ther. 2002 Nov;303(2):487–496.
   PubMed Web of Science ®Google Scholar
• Kwok B, Yamauchi A, Rajesan R, et al. Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A. Am J Physiol Regul Integr Comp Physiol. 2006 Mar;290(3):R793–802.
   PubMed Web of Science ®Google Scholar
• Kimura S, Morimoto K, Okamoto H, et al. Development of a human mammary epithelial cell culture model for evaluation of drug transfer into milk. Arch Pharm Res. 2006 May;29(5):424–429.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Sun R, et al. The treatment value of IL-1β monoclonal antibody under the targeting location of alpha-methyl-L-tryptophan and superparamagnetic iron oxide nanoparticles in an acute temporal lobe epilepsy model. J Transl Med. 2018 Dec 4;16(1):337.
   PubMedGoogle Scholar
• Johnson AC, Hammer ES, Sakkaki S, et al. Inhibition of blood-brain barrier efflux transporters promotes seizure in pregnant rats: role of circulating factors. Brain Behav Immun. 2018 Jan;67:13–23.
   PubMed Web of Science ®Google Scholar
• Morin-Brureau M, Lebrun A, Rousset MC, et al. Epileptiform activity induces vascular remodeling and zonula occludens 1 downregulation in organotypic hippocampal cultures: role of VEGF signaling pathways. J Neurosci. 2011 Jul 20;31(29):10677–10688.
   PubMed Web of Science ®Google Scholar
• Librizzi L, Vila Verde D, Colciaghi F, et al. Peripheral blood mononuclear cell activation sustains seizure activity. Epilepsia. 2021 Jul;62(7):1715–1728.
   PubMed Web of Science ®Google Scholar
• Runtz L, Girard B, Toussenot M, et al. Hepatic and hippocampal cytochrome P450 enzyme overexpression during spontaneous recurrent seizures. Epilepsia. 2018 Jan;59(1):123–134.
   PubMed Web of Science ®Google Scholar
• Li YJ, Wang ZH, Zhang B, et al. Disruption of the blood-brain barrier after generalized tonic-clonic seizures correlates with cerebrospinal fluid MMP-9 levels. J Neuroinflammation. 2013 Jul 5;10:80.
   PubMed Web of Science ®Google Scholar
• Milesi S, Boussadia B, Plaud C, et al. Redistribution of PDGFRβ cells and NG2DsRed pericytes at the cerebrovasculature after status epilepticus. Neurobiol Dis. 2014;71:151–158.
   PubMed Web of Science ®Google Scholar
• Ivens S, Kaufer D, Flores LP, et al. TGF-beta receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis. Brain. 2007 Feb;130(Pt 2):535–547.
   PubMed Web of Science ®Google Scholar
• Thomas SV, Jose M, Divakaran S, et al. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: results from a pregnancy registry in South India. Epilepsia. 2017 Feb;58(2):274–281.
   PubMed Web of Science ®Google Scholar
• Han L, Jiang C. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies. Acta Pharm Sin B. 2021 Aug;11(8):2306–2325.
   PubMed Web of Science ®Google Scholar
• Gao H. Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B. 2016 Jul;6(4):268–286.
   PubMed Web of Science ®Google Scholar
• Ahmadimoghaddam D, Zemankova L, Nachtigal P, et al. Organic cation transporter 3 (OCT3/SLC22A3) and multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter in the placenta and fetal tissues: expression profile and fetus protective role at different stages of gestation. Biol Reprod. 2013 Mar;88(3):55.
   PubMed Web of Science ®Google Scholar
• Nozohouri S, Noorani B, Al-Ahmad A, et al. Estimating Brain Permeability Using In Vitro Blood-Brain Barrier Models. Methods Mol Biol. 2021;2367:47–72.
   PubMedGoogle Scholar
• Wang YI, Abaci HE, Shuler ML. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening. Biotechnol Bioeng. 2017 Jan;114(1):184–194.
   PubMed Web of Science ®Google Scholar
• Oddo A, Peng B, Tong Z, et al. Advances in Microfluidic Blood-Brain Barrier (BBB) Models. Trends Biotechnol. 2019 Dec;37(12):1295–1314.
   PubMed Web of Science ®Google Scholar
• Vatine GD, Barrile R, Workman MJ, et al. Human iPSC-Derived Blood-Brain Barrier Chips Enable Disease Modeling and Personalized Medicine Applications. Cell Stem Cell. 2019 Jun 6;24(6):995–1005.e6.
   PubMed Web of Science ®Google Scholar
• Park TE, Mustafaoglu N, Herland A, et al. Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies. Nat Commun. 2019 Jun 13;10(1):2621.
   PubMedGoogle Scholar
• Blundell C, Yi YS, Ma L, et al. Placental Drug Transport-on-a-Chip: a Microengineered In Vitro Model of Transporter-Mediated Drug Efflux in the Human Placental Barrier. In:Goebel U, editor. Adv Healthc Mater. Hoboken, NJ. Vol. 7. 2018 Jan. p. 2.
   Google Scholar
• Yin F, Zhu Y, Zhang M, et al. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol In Vitro. 2019;54:105–113.
   PubMed Web of Science ®Google Scholar
• Song K, Zu X, Du Z, et al. Diversity Models and Applications of 3D Breast Tumor-on-a-Chip. Micromachines (Basel). 2021 12;12(7):Jul.
   Web of Science ®Google Scholar
• Subia B, Dahiya UR, Mishra S, et al. Breast tumor-on-chip models: from disease modeling to personalized drug screening. J Control Release. 2021 Mar;10(331):103–120.
   Google Scholar
• Mark D, Haeberle S, Roth G, et al. Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. Chem Soc Rev. 2010 Mar;39(3):1153–1182.
   PubMed Web of Science ®Google Scholar
• Wang X, Qi B, Su H, et al. Pyrilamine-sensitive proton-coupled organic cation (H(+)/OC) antiporter for brain-specific drug delivery. J Control Release. 2017 May;28(254):34–43.
   Google Scholar
• Charalambous M, Volk HA, Tipold A, et al. Comparison of intranasal versus intravenous midazolam for management of status epilepticus in dogs: a multi-center randomized parallel group clinical study. J Vet Intern Med. 2019 Nov;33(6):2709–2717.
   PubMed Web of Science ®Google Scholar
• von Blomberg A, Kay L, Knake S, et al. Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring. CNS Drugs. 2020 May;34(5):545–553.
   PubMed Web of Science ®Google Scholar
• Segal EB, Tarquinio D, Miller I, et al. Evaluation of diazepam nasal spray in patients with epilepsy concomitantly using maintenance benzodiazepines: an interim subgroup analysis from a phase 3, long-term, open-label safety study. Epilepsia. 2021 Jun;62(6):1442–1450.
   PubMed Web of Science ®Google Scholar
• Achar A, Myers R, Ghosh C. Drug Delivery Challenges in Brain Disorders across the Blood-Brain Barrier: novel Methods and Future Considerations for Improved Therapy. Biomedicines. 2021 4;9(12):Dec.
   Web of Science ®Google Scholar
• Wang Z, Zhang C, Huang F, et al. Breakthrough of ZrO(2) nanoparticles into fetal brains depends on developmental stage of maternal placental barrier and fetal blood-brain-barrier. J Hazard Mater. 2021 Jan 15;402:123563.
   PubMed Web of Science ®Google Scholar
• Kuze K, Graves P, Leahy A, et al. Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells. J Biol Chem. 1999 Jan 15;274(3):1519–1524.
   PubMed Web of Science ®Google Scholar
• Geddes JR, Gardiner A, Rendell J, et al. Comparative evaluation of quetiapine plus lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in bipolar depression (CEQUEL): a 2 × 2 factorial randomised trial. Lancet Psychiatry. 2016 Jan;3(1):31–39.
   PubMed Web of Science ®Google Scholar